The biggest study into the issue linked using two wheels with a halving of the risk of cancer and heart disease.

The five-year study of 250,000 UK commuters also showed walking had some benefits over sitting on public transport or taking the car.

The team in Glasgow said cycling took no willpower once it became part of the work routine – unlike going to the gym.

The five-year study compared people who had an “active” commute with those who were mostly stationary.

‘Active commuters’

Overall, 2,430 of those studied died, 3,748 were diagnosed with cancer and 1,110 had heart problems.

But, during the course of the study, regular cycling cut the risk of death from any cause by 41%, the incidence of cancer by 45% and heart disease by 46%.

The cyclists clocked an average of 30 miles per week, but the further they cycled the greater the health boon.

Walking cut the odds of developing heart disease but the benefit was mostly for people walking more than six miles per week.

“This is really clear evidence that people who commute in an active way, particularly by cycling, were at lower risk,” Dr Jason Gill, from the University of Glasgow, told the BBC News website.

“You need to get to work every day so if you built cycling into the day it essentially takes willpower out of the equation.

“What we really need to do is change our infrastructure to make it easier to cycle – we need bike lanes, to make it easier to put bikes on trains, showers at work.”

People who combined cycling and public transport in their commute also showed health benefits.

Out of breath

The way the study, published in the British Medical Journal, was carried out means it is not possible to determine a clear cause and effect.

However, the effect was still there even after adjusting the statistics to remove the effects of other potential explanations like smoking, diet or how heavy people are.

It means the reason cycling cuts cancer risk cannot be down to weight loss in the study.

Other explanations include cyclists being leaner (even if they are not weighing any less) and lower levels of inflammation in the body.

Cycling is thought to be better than walking as the exercise is both longer and more intense.

Clare Hyde from Cancer Research UK said: “This study helps to highlight the potential benefits of building activity into your everyday life.

“You don’t need to join a gym or run the marathon.

“Anything that gets you a bit hot and out of breath – whether it’s cycling all or part way to work or doing some housework – can help make a difference.”

–

Source: BBC

The post Cycling to work can cut cancer and heart disease, says study appeared first on Citi 97.3 FM - Relevant Radio. Always.

Tumours can “seed” themselves elsewhere in the body and this process is behind 90% of cancer deaths.

The mouse study, published in Nature, showed altering the immune system slowed the spread of skin cancers to the lungs.

Cancer Research UK said the early work gave new insight into how tumours spread and may lead to new treatments.

The spread of cancer – known as metastasis – is a fight between a rapidly mutating cancer and the rest of the body.

The team at the Sanger Institute in Cambridge was trying to figure out what affected tumour spread in the body.

Researchers created 810 sets of genetically modified lab mice to discover which sections of the DNA were involved in the body resisting a cancer’s spread.

The animals were injected with melanomas (skin cancer) and the team counted the number of tumours that formed in the lung.

Their hunt led them to discover 23 sections of DNA, or genes, that made it either easier or harder for a cancer to spread.

Many of them were involved in controlling the immune system.

Targeting one gene – called Spns2 – led to a three-quarters reduction in tumours spreading to the lungs.

‘Interesting biology’

“It regulated the balance of immune cells within the lung,” Dr David Adams, one of the team, told the BBC News website.

“It changes the balance of cells that play a role in killing tumour cells and those that switch off the immune system.”

The field of immunotherapy – harnessing the power of the immune system to fight cancer – has delivered dramatic results for some patients.

A rare few with a terminal diagnosis have seen all signs of cancer disappear from their body, although the drugs still fail to work in many patients.

Dr Adams said: “We’ve learnt some interesting new biology that we might be able to use – it’s told us this gene is involved in tumour growth.”

Drugs that target Spns2 could produce the same cancer-slowing effect but that remains a distant prospect.

Dr Justine Alford, from Cancer Research UK, said: “This study in mice gives a new insight into the genes that play a role in cancer spreading and may highlight a potential way to treat cancer in the future.

“Cancer that has spread is tough to treat, so research such as this is vital in the search for ways to tackle this process.”

–

Source: BBC

The post Cancer spread cut by 75% in tests appeared first on Citi 97.3 FM - Relevant Radio. Always.